To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
From the brink 21 years ago, IVP now stronger than ever
The late-stage investor announced in early October that its 116th portfolio company, telemed start-up Hims & Hers, will go public via a SPAC. But IVP’s future was not always as clear.
